Biomea Fusion Stock (NASDAQ: BMEA) stock price, news, charts, stock research, profile.
You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.
Other companies in Biomea Fusion’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Inozyme Pharma (NASDAQ:INZY) and Fate Therapeutics (NASDAQ:FATE).
Biomea Fusion has a consensus price target of $34.41.
The stock price for Biomea Fusion (NASDAQ: BMEA) is $6.53 last updated November 15, 2024 at 4:00 PM EST.
There are no upcoming dividends for Biomea Fusion.
Biomea Fusion’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Biomea Fusion.
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.